Armstrong R A
Department of Dietetics & Nutrition, Queen Margaret College, Edinburgh, Scotland.
Pharmacol Ther. 1996;72(3):171-91. doi: 10.1016/s0163-7258(96)00103-9.
Prostaglandins (PGs) and thromboxanes are important modulators of platelet activation, and there is strong evidence to support the existence of distinct thromboxane, prostacyclin, PGD2 and PGE2 receptors on the platelet plasma membrane. In this review, each of these platelet prostanoid receptors is discussed in detail, with respect to their receptor pharmacology, molecular biology and signal transduction, and as to any therapeutic implications of the development of specific agonists and/or antagonists. In addition, it considers the possibility that there are separate vascular receptors for 8-epi PGF2 alpha, which are not present on the platelet.
前列腺素(PGs)和血栓素是血小板活化的重要调节因子,有充分证据支持血小板质膜上存在不同的血栓素、前列环素、前列腺素D2和前列腺素E2受体。在这篇综述中,将详细讨论这些血小板类前列腺素受体中的每一种,涉及其受体药理学、分子生物学和信号转导,以及特定激动剂和/或拮抗剂开发的任何治疗意义。此外,还考虑了8-表前列腺素F2α存在独立的血管受体而血小板上不存在这种受体的可能性。